KANSAS CITY, Kan., Nov. 20, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, announced plans to participate in two upcoming investor events. Aratana will join a fireside chat at Piper Jaffray's 27th Healthcare Conference in New York City on December 1, 2015 at 12 p.m. ET. Additionally, Aratana will present at the Bank of America Merrill Lynch 2015 Animal Health Summit in Boston on December 16, 2015 at 8 a.m. ET.
The events will not be available via webcast. Interested parties may view the presentation slides in the Aratana Investor Room after each event.
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.
SOURCE Aratana Therapeutics, Inc.